Status:
COMPLETED
Comparative Study of Rocuronium With Vecuronium (Study 71101)(COMPLETED)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Anesthesia
Eligibility:
All Genders
20-65 years
Phase:
PHASE3
Brief Summary
This study was conducted to determine and compare the safety and effectiveness of two neuromuscular blockers (rocuronium and vecuronium) at various doses in adults who are undergoing general elective ...
Detailed Description
The TOF Watch-SX (acceleration transducer) was used in the measurement of neuromuscular blocking action.
Eligibility Criteria
Inclusion
- Inclusion criteria:
- at least 20 but under 65 years of age
- American Society of Anesthesiologists (ASA) Class 1, 2 or 3 for general elective surgery
- not considered to be pregnant
- scheduled for elective surgery under sevoflurane or propofol anesthesia with an anticipated duration of about 1.5-3 hours
- normal laboratory values
- Exclusion Criteria:
- certain medical conditions or medical histories
- receiving certain medications or treatments
Exclusion
Key Trial Info
Start Date :
February 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2004
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT00970762
Start Date
February 1 2003
End Date
February 1 2004
Last Update
April 17 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.